Demystify Aztreonam/Avibactam for Abdominal Infections
September 2025
Questions are swirling around the role of aztreonam/avibactam (Emblaveo)...due to debate around the evidence to support its use.
This new IV antibiotic combines aztreonam with avibactam, a beta-lactamase inhibitor, in a 3:1 ratio.
It’s approved for adults with complicated intra-abdominal infections (cIAI)...perforated appendicitis, cholecystitis, etc. Plus it works against extended-spectrum beta-lactamases and some carbapenemases.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote